Infrequent mutation of ATBF1 in human breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 2, 2007, Pages 103-105

  Sun, Xiaodong ^a   Zhou, Yingfa ^a   Otto, Kristen B ^a   Wang, Mingrong ^a,b   Chen, Ceshi ^a   Zhou, Wei ^a   Subramanian, Krithika ^a   Vertino, Paula M ^a   Dong, Jin Tang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CANCER HOSPITAL   (China)

Author keywords

ATBF1; Breast cancer; Expression; Mutation

Indexed keywords

AT MOTIF BINDING FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; DOWN-REGULATION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MUTATION; POLYMORPHISM, GENETIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 33845622500     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0148-y     Document Type: Article

References (22)

1. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925
2. Bieche I, Lidereau R (1995) Genetic alterations in breast cancer. Genes Chromosomes Cancer 14:227-251
3. Callen DF, Crawford J, Derwas C, Cleton-Jansen AM, Cornelisse CJ, Baker E (2002) Defining regions of loss of heterozygosity of 16q in breast cancer cell lines. Cancer Genet Cytogenet 133:76-82
4. Chen C, Bhalala HV, Qiao H, Dong JT (2002) A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21:6567-6572
5. Cleton-Jansen AM (2002) E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 4:5-8
6. Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17:499-508
7. Gronwald J, Jauch A, Cybulski C, Schoell B, Bohm-Steuer B, Lener M, Grabowska E, Gorski B, Jakubowska A, Domagala W, Chosia M, Scott RJ, Lubinski J (2005) Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 114:230-236
8. Kaspar P, Dvorakova M, Kralova J, Pajer P, Kozmik Z, Dvorak M (1999) Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J Biol Chem 274:14422-14428
9. Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T, Itoh M (2001) Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene 20:869-873
10. Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K (2003) ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res 63:5785-5792
11. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y (1999) DNA copy number losses in human neoplasms. Am J Pathol 155:683-694
12. Miura Y, Kataoka H, Joh T, Tada T, Asai K, Nakanishi M, Okada N, Okada H (2004) Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Microbiol Immunol 48:137-145
13. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T (1991) A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol 11:6041-6049
14. Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO (2005) High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Int J Cancer 114:720-729
15. Shibata Y, Miura Y, Tada T, Otsuka T, Asai K, Kato T, Matsui N (2001) Functional analysis of ATBF1, a multiple-homeodomain zinc finger protein, using lung cancer cell line A549. Nagoya Med J 45:31
16. Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BL, Vessella RL, Gao AC, Petros J, Miura Y, Simons JW, Dong JT (2005) Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 37:407-412
17. Vos CB, ter Haar NT, Rosenberg C, Peterse JL, Cleton-Jansen AM, Cornelisse CJ, van de Vijver MJ (1999) Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer 81:1410-1418
18. Watanabe A, Hippo Y, Taniguchi H, Iwanari H, Yashiro M, Hirakawa K, Kodama T, Aburatani H (2003) An opposing view on WWOX protein function as a tumor suppressor. Cancer Res 63:8629-8633
19. van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM (2005) Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Res 7:R998-R1004
20. Widschwendter M, Jones PA (2002) DNA methylation and breast carcinogenesis. Oncogene 21:5462-5482
21. Yasuda H, Mizuno A, Tamaoki T, Morinaga T (1994) ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene. Mol Cell Biol 14:1395-1401
22. Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H (2005) ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Clin Cancer Res 11:193-198